SEI Investments’s Ovid Therapeutics OVID Stock Holding History

SEI Investments’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$529K	Sell	196,685 -132,239	-40%	-$341K	﹤0.01%	2613
2026 Q1	$730K	Buy	+328,924	New	+$588K	﹤0.01%	2511
2023 Q1	–	Sell	-33,832	Closed	-$62.9K	–	2722
2022 Q4	$62.9K	Hold	33,832	–	–	﹤0.01%	2476
2022 Q3	$62K	Sell	33,832 -39,156	-54%	-$81.9K	﹤0.01%	2608
2022 Q2	$157K	Sell	72,988 -46,366	-39%	-$112K	﹤0.01%	2515
2022 Q1	$375K	Hold	119,354	–	–	﹤0.01%	2211
2021 Q4	$383K	Buy	119,354 +38,657	+48%	+$132K	﹤0.01%	2249
2021 Q3	$271K	Hold	80,697	–	–	﹤0.01%	2348
2021 Q2	$316K	Buy	+80,697	New	+$318K	﹤0.01%	2290
2018 Q3	–	Sell	-97	Closed	-$1K	–	3151
2018 Q2	$1K	Buy	+97	New	+$833	﹤0.01%	3497

Other funds holding OVID

Jupiter Topco New York $245B AUM

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

SEI Investments's OVID Position: Q2 2026 in Review

SEI Investments reduced its Ovid Therapeutics (OVID) stake by 40% in Q2 2026, selling an estimated $341K and leaving 196,685 shares worth $529K. The position accounts for ﹤0.01% of the portfolio, ranked #2613.

SEI Investments first reported a position in OVID in Q2 2018 and has held it in 10 quarters since. The position peaked at $730K in Q1 2026. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

SEI Investments held 196,685 shares of Ovid Therapeutics worth $529K as of Q2 2026.
SEI Investments sold 132,239 Ovid Therapeutics shares in Q2 2026, an estimated $341K.
Ovid Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2613 holding.
SEI Investments first reported a position in Ovid Therapeutics in Q2 2018 and has held it in 10 quarters since.
SEI Investments's Ovid Therapeutics position peaked at $730K in Q1 2026.
130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.